Skip to main content
NCBI home page
Annals of Noninvasive Electrocardiology logoLink to Annals of Noninvasive Electrocardiology
. 2006 Oct 27;7(3):251–262. doi: 10.1111/j.1542-474X.2002.tb00172.x

Brugada Syndrome: Current Clinical Aspects and Risk Stratification

Takanori Ikeda 1,✉
PMCID: PMC7027682  PMID: 12167188

Abstract

Brugada syndrome is a primary electrical disease of the heart that causes sudden cardiac death or life‐threatening ventricular arrhythmias, especially in younger men. Genetic analysis supports that this syndrome is a cardiac ion channel disease. A typical electrocardiographic finding consists of a right bundle branch block pattern and ST‐segment elevation in the right precordial leads. The higher intercostal space V1 to V3 lead electrocardiogram could be helpful in detecting Brugada patients. Although two types of the ST‐segment elevation are present, the coved type is more relevant to the syndrome than the saddle‐back type. These patterns can be present permanently or intermittently. Recent data suggest that the Brugada‐type electrocardiogram is more prevalent than the manifest Brugada syndrome. Asymptomatic individuals have a much lower incidence of future cardiac events than the symptomatic patients. Although risk stratification for the Brugada syndrome is still incomplete, the inducibility of sustained ventricular arrhythmias has been proposed as a good outcome predictor in this syndrome. In noninvasive techniques, some clinical evidence supports that late potentials detected by signal‐averaged electrocardiography are a useful index for identifying patients at risk. The available data recommend prophylactic implantation of an imptantabie cardioverter defibrillator to prevent sudden cardiac death. This review summarizes recent information of the syndrome by reviewing most of new clinical reports and speculates on its risk stratification. A.N.E. 2002;7(3):251–262

Keywords: Brugada syndrome, sudden cardiac death, ventricular fibrillation, risk stratification, signal‐averaged electrocardiography, electrophysiological study

REFERENCES

  • 1. Brugada P, Brugada J. Right bundle branch block, persistent ST‐segment elevation and sudden cardiac death. A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391–1396. [DOI] [PubMed] [Google Scholar]
  • 2. Brugada P, Brugada J, Brugada R. The Brugada syndrome. Ann Noninvasive Electrocardiol 2000;5:88–91. [Google Scholar]
  • 3. Priori SG, Napolitano C, Giordano U, et al. Brugada syndrome as a cause of sudden cardiac death in children. Lancet 2000;355:808–809. [DOI] [PubMed] [Google Scholar]
  • 4. Alings M, Wilde A: “Brugada” syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666–673. [DOI] [PubMed] [Google Scholar]
  • 5. Guassak I, Antzelevitch C, Bjerregaard P, et al. The Brugada syndrome. Clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 1999;33: 5–15. [DOI] [PubMed] [Google Scholar]
  • 6. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998;392:293–296. [DOI] [PubMed] [Google Scholar]
  • 7. Kalla H, Yan G‐X, Marinchak R. Ventricular fibrillation in a patient with prominent J (Osborn) waves and ST‐segment elevation in the inferior electrocardiographic leads. A Brugada syndrome variant J Cardiovasc Electrophysiol 2000;11:95–98. [DOI] [PubMed] [Google Scholar]
  • 8. Takagi M, Aihara N, Takaki H, et al. Clinical characteristics of patients with spontaneous or inducible ventricular fibrillation without apparent heart disease presenting with J wave and ST‐segment elevation in inferior leads. J Cardiovasc Electrophysiol 2000;11:844–848. [DOI] [PubMed] [Google Scholar]
  • 9. Eckard L, Kirchhof P, Loh P, et al. Brugada syndrome and supraventricular tachyarrhythmias. A novel association J Cardiovasc Electrophysiol 2001; 12:680–685. [DOI] [PubMed] [Google Scholar]
  • 10. Hermida J.S, Lemoine J.L, Aoun FB, et al. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86:91–94. [DOI] [PubMed] [Google Scholar]
  • 11. Viskin S, Fish R, Eldar M, et al. Prevalence of the Brugada signs in idiopathic ventricular fibrillation and healthy controls. Heart 2000;84:31–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Monroe MH, Littmann L. Two‐year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital. Clin Cardiol 2000;23:849–851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Miyasaka Y, Tsuji H, Yamada K, et al. Prevalence and mortality of the Brugada‐type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001;38:771–774. [DOI] [PubMed] [Google Scholar]
  • 14. Matsuo K, Akahoshi M, Nakashima E, et al. The prevalence, incidence and prognostic value of the Brugada‐type electrocardiogram: A population‐based study of four decades. J Am Coll Cardiol 2001;38:765–770. [DOI] [PubMed] [Google Scholar]
  • 15. Furuhashi M, Uno K, Tsuchihashi K, et al. Prevalence of asymptomatic ST‐segment elevation in the right precordial leads with right bundle branch block (Brugada‐type ST shift) among the general Japanese population. Heart 2001;86:161–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Brugada P, Geelen P, Brugada R, et al. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:1004–1007. [DOI] [PubMed] [Google Scholar]
  • 17. Priori SG. Foretelling the future in Brugada syndrome. Do we have the crystal ball J Cardiovasc Electrophysiol 2001;12:1008–1009. [DOI] [PubMed] [Google Scholar]
  • 18. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of non‐invasive markers in identifying patients at risk in the Brugada syndrome. Insight into risk stratification. J Am Coll Cardiol 2001;37: 1628–1634. [DOI] [PubMed] [Google Scholar]
  • 19. Antzelevitch C. The Brugada syndrome. Diagnostic criteria and cellular mechanism. Eur Heart J 2001;22: 356–363. [DOI] [PubMed] [Google Scholar]
  • 20. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST‐segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510–515. [DOI] [PubMed] [Google Scholar]
  • 21. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST‐segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27:1061–1070. [DOI] [PubMed] [Google Scholar]
  • 22. Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997;95:2277–2285. [DOI] [PubMed] [Google Scholar]
  • 23. Krishnan SC, Josephson ME. ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug‐induced proarrhythmia. J Cardiovasc Electrophysiol 1998;9:1167–1172. [DOI] [PubMed] [Google Scholar]
  • 24. Fujiki A, Usui M, Nagasawa H, et al. ST‐segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs. Insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 1999;10: 214–218. [DOI] [PubMed] [Google Scholar]
  • 25. Shimizu W, Matsuo K, Takagi M, et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome. Clinical implication of eight‐seven‐lead body surface potential mapping and its application to twelve‐lead electrocardiograms. J Cardiovasc Electrophysiol 2000;11: 396–404. [DOI] [PubMed] [Google Scholar]
  • 26. Ortega‐Carnicer J, Bertos‐Polo J, Gutierrez‐Tirado C. Aborted sudden death, transient Brugada pattern and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol 2001;34:345–349. [DOI] [PubMed] [Google Scholar]
  • 27. Pastor A, Nunez A, Cantale C, et al. Asymptomatic Brugada syndrome case of unmasking during dimenhydrioate infusion. J Cardiovasc Electrophysiol 2001;12:1192–1194. [DOI] [PubMed] [Google Scholar]
  • 28. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhyth‐mogenic marker for the sudden death unexplained death syndrome in Thai men. Circulation 1997;96:2595–2600. [DOI] [PubMed] [Google Scholar]
  • 29. Matsuo K, Simizu W, Kurita T, et al. Dynamic changes of 12‐lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998;9:508–512. [DOI] [PubMed] [Google Scholar]
  • 30. Stix G, Bella PD, Carbucicchio C, et al. Spatial and temporal heterogeneity of depolarization and repolarizatkm may complicate implantable cardioverter defibrillator therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:516–521. [DOI] [PubMed] [Google Scholar]
  • 31. Lee KL, Lau C‐P, Tse H‐F, et al. Prevention of ventricular fibrillation by pacing in a man with Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:935–937. [DOI] [PubMed] [Google Scholar]
  • 32. Yan G‐X, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogeaesis associated with ST‐segment elevation. Circulation 1999;100:1660–1666. [DOI] [PubMed] [Google Scholar]
  • 33. Garg A, Finneran W, Feld GK. Familial sudden cardiac death associated with a terminal QRS abnormality on a surface 12‐lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998;9:642–647. [DOI] [PubMed] [Google Scholar]
  • 34. Alings M, Dekker L, Sadee A, et al. Quirudine‐induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001;24:1420–1422. [DOI] [PubMed] [Google Scholar]
  • 35. Sangwatanaroj S, Prechawat S, Sunsaneewitayatad B, et al. New electrocardiographic leads the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 2001;22:2290–2296. [DOI] [PubMed] [Google Scholar]
  • 36. Remme CA, Wever EFD, Wilde AAM, et al. Diagnosis and long‐term follow‐up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J 2001;22:400–409. [DOI] [PubMed] [Google Scholar]
  • 37. Brugada J, Brugada R, Brugada P. Right bundle branch block and ST‐segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97: 457–460. [DOI] [PubMed] [Google Scholar]
  • 38. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST‐segment elevation syndrome. A prospective evaluation of 52 families. Circulation 2000;102: 2509–2515. [DOI] [PubMed] [Google Scholar]
  • 39. Suzuki H, Torigoe K, Numata O, et al. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:1277–1280. [DOI] [PubMed] [Google Scholar]
  • 40. Corrado D, Basso C, Buja G, et al. Right bundle branch block, right precordial ST‐segment elevation and sadden death in young people. Circulation 2001;103:710–717. [DOI] [PubMed] [Google Scholar]
  • 41. Brugada J, Brugada R, Antzelevitch C, et al. Long term follow‐up of individuals with the electrocardiographic pattern of right bundle‐branch block and ST‐segment elevation in precordial leads V1 to V3. Circulation 2002;10573–78. [DOI] [PubMed]
  • 42. Atarashi H, Ogawa S, Harumi K, et al. Three‐year follow‐up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese registry of Brugada syndrome. J Am Coll Cardiol 2001;37:1916–1920. [DOI] [PubMed] [Google Scholar]
  • 43. Takenaka S, Kusano K, Hisamatsu K, et al. Relatively benign clinical course in asymptomatic patients with Brugada‐type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol 2001;12:2–6. [DOI] [PubMed] [Google Scholar]
  • 44. Brugada R, Roberts R. Brugada syndrome. Why are there multiple answers to a simple question Circulation 2001;104:3017–3019. [PubMed] [Google Scholar]
  • 45. Geller JC, Reek S, Goette A, Klein HU. Spontaneous episode of polymorphic ventricular tachycardia in a patient with intermittent Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:1094. [DOI] [PubMed] [Google Scholar]
  • 46. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation 2002;105: 1342–1347. [DOI] [PubMed] [Google Scholar]
  • 47. Bermudez EP, Garcia‐Alberola A, Sanchez JM, et al. Spontaneous sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome. PACE 2000;23:407–409. [DOI] [PubMed] [Google Scholar]
  • 48. Ogawa M, Kumagai K, Saku K. Spontaneous right ventricular outflow tract tachycardia in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:838–840. [DOI] [PubMed] [Google Scholar]
  • 49. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999;20:465–470. [DOI] [PubMed] [Google Scholar]
  • 50. Samniah N, Iskos D, Sakaguchi S, et al. Syncope in pharmacologically unmasked Brugada syndrome. Indication for an implantable defibrillator or an unresolved dilemma? Europace 2001;3:159–163. [DOI] [PubMed] [Google Scholar]
  • 51. Itoh H, Shimizu M, Ino H, et al. Arrhythmias in patients with Brugada‐type electrocardiographic findings. Jpn Circ J 2001;65:483–486. [DOI] [PubMed] [Google Scholar]
  • 52. Wichter T, Matheja P, Eckardt L, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 2002;105:702–706. [DOI] [PubMed] [Google Scholar]
  • 53. Kobayashi T, Shintani U, Yamamoto T, et al. Familial occurrence of electrocardiographic abnormalities of the Brugada‐type. Intern Med 1996;35:637–640. [DOI] [PubMed] [Google Scholar]
  • 54. Gussak I, Bjerregaard P, Hammill SC. Clinical diagnosis and risk stratification in patients with Brugada syndrome. J Am Coll Cardiol 2001;37:1635–1638. [DOI] [PubMed] [Google Scholar]
  • 55. Toda H, Nogami A, Shimizu W, et al. ST‐segment and T‐wave alternans in a patient with Brugada syndrome. PACE 2000;23:413–415. [DOI] [PubMed] [Google Scholar]
  • 56. Chinushi M, Washizuka T, Okumura H, et al. Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001;12:493–495. [DOI] [PubMed] [Google Scholar]
  • 57. Takagi M, Aihara N, Kuribayashi S, et al. Localized right ventricular morphological abnormalities detected by electron‐beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J 2001;22:1032–1041. [DOI] [PubMed] [Google Scholar]
  • 58. Brugada P, Brugada J, Brugada R. Localized” right ventricular morphological abnormalities in patients with the Brugada syndrome. What is their significance Eur Heart J 2001;22:982–984. [DOI] [PubMed] [Google Scholar]
  • 59. Eckardt L, Kirchhof P, Schulze‐Bahr E, et al. Mode of induction of ventricular tachyarrhythmias in Brugada syndrome. PACE 2001;24:558. [Google Scholar]
  • 60. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long‐QT syndrome. Cell 1995;80:805–811. [DOI] [PubMed] [Google Scholar]
  • 61. Dumaine R, Towgin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999;85:803–809. [DOI] [PubMed] [Google Scholar]
  • 62. Bezzina C, Veldkamp MW, van Den Berg MP, et al. A single Na+ channel mutation causing both long‐QT and Brugada syndromes. Circ Res 1999;85:1206–1213. [DOI] [PubMed] [Google Scholar]
  • 63. Makita N, Shirai N, Wang DW, et al. Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)‐subunit. Circulation 2000;101:54–60. [DOI] [PubMed] [Google Scholar]
  • 64. Veldkamp MW, Viswanathan PC, Bezzina C, et al. Two distinct congenital arrhythmias evoked by a multidysfunc‐tional Na+ channel. Circ Res 2000;86:E91–E97. [DOI] [PubMed] [Google Scholar]
  • 65. Wang DW, Makita N, Kitabatake A, et al. Enhanced sodium channel intermediate activation in Brugada syndrome. Circ Res 2000;87:E37–E43. [DOI] [PubMed] [Google Scholar]
  • 66. Baroudi G, Pouliot V, Denjoy I, et al. Novel mechanism for Brugada syndrome. Defective surface localization of an SCN5A mutant (R1432G). Circ Res 2001;88:E78–E83. [DOI] [PubMed] [Google Scholar]
  • 67. Viswanathan PC, Bezzina CR, George AL Jr, et al. Gating‐dependent mechanisms for flecainide action in SCN5A‐linked arrhythmia syndromes. Circulation 2001;104:1200–1205. [DOI] [PubMed] [Google Scholar]
  • 68. Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001;104:3081–3086. [DOI] [PubMed] [Google Scholar]
  • 69. Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block, ST segment elevation in V1 to V3 and sudden death. The Brugada syndrome. Europace 1999;1: 156–166. [DOI] [PubMed] [Google Scholar]
  • 70. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646–1653. [DOI] [PubMed] [Google Scholar]
  • 71. Priori SG, Aliot E, Blomstrom‐Lundqvist C, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001;22:1374–1450. [DOI] [PubMed] [Google Scholar]
  • 72. Belhassen B, Viskin S, Fish R, et al. Effects of electrophysiologic‐guided therapy with class IA antiarrhythmic drugs on the long‐term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10:1301–1312. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Noninvasive Electrocardiology are provided here courtesy of International Society for Holter and Noninvasive Electrocardiology, Inc. and Wiley Periodicals, Inc.

RESOURCES